Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2018

Nov 20, 2018

30071_dirs_2018-11-20_86fa97b5-0d2c-40b5-b7a3-852f21989217.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2018-11-16

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-11-16 ResMed Common Stock A 13640 Acquired 13640 Indirect
2018-11-16 ResMed Common Stock G 3300 Disposed 10340 Indirect
2018-11-16 ResMed Common Stock G 3300 Acquired 3300 Indirect
2018-11-16 ResMed Common Stock S 3300 $104.49 Disposed 0 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
ResMed Common Stock 240487 Direct

Footnotes

F1: Acquisition originates from a maturity distribution of the Charitable Income Trust II to beneficiaries.

F2: Represents a gift to the Lisette and Michael Farrell Family Foundation, a 501(c)(3) non-profit corporation.

F3: Mr. and Mrs. Farrell retain dispositive power over foundation holdings.